Evidence map›Paper›PMID 33046450›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Translating Cancer Risk Prediction Models into Personalized Cancer Risk Assessment Tools: Stumbling Blocks and Strategies for Success.

Erika A Waters, Jennifer M Taber, Amy McQueen, Ashley J Housten, Jamie L Studts, Laura D Scherer

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Patient and Physician Perspectives on Using Risk Prediction to Support Breast Cancer Surveillance Decision Making.Medical decision making : an international journal of the Society for Medical Decision Making · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Testing Explanations for Skepticism of Personalized Risk Information.Medical decision making : an international journal of the Society for Medical Decision Making · 2023
    Article
  16. Development and validation of the lung donor (LUNDON) acceptability score for pulmonary transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Erika A WatersWashington University School of Medicine, St. Louis, Missouri. waterse@wustl.edu.
Jennifer M TaberKent State University, Kent, Ohio.ORCID 0000-0003-3285-4871
Amy McQueenWashington University School of Medicine, St. Louis, Missouri.ORCID 0000-0003-0332-3983
Ashley J HoustenWashington University School of Medicine, St. Louis, Missouri.
Jamie L StudtsUniversity of Colorado School of Medicine, Denver, Colorado.
Laura D SchererUniversity of Colorado School of Medicine, Denver, Colorado.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
COMMUNICATING MULTIPLE DISEASE RISKS: A TRANSLATION OF RISK PREDICTION SCIENCER01CA190391 · NCI · WASHINGTON UNIVERSITY · PI WATERS, ERIKA A · 2015 to 2018
$1.4M
Breast Cancer Screening: Priorities and Attitudes of Diverse Women Under 50R00MD011485 · NIMHD · WASHINGTON UNIVERSITY · PI HOUSTEN, ASHLEY · 2019 to 2021
$712k
NCATS NIH HHS UL1 TR002345NCI NIH HHS R01 CA190391NIMHD NIH HHS R00 MD011485
6 · The paper itself

Abstract

Cancer risk prediction models such as those published in

Indexed as

HumansNeoplasmsPrecision MedicineRisk Assessment

Identifiers

PMID33046450
PMCPMC8170537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.